Author

Timothy Hoops

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY

Timothy Hoops  et al.

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Timothy Hoops  et al.

IMPACT OF TREATMENT SWITCH ON CLINICAL OUTCOMES IN CROHN’S DISEASE PATIENTS IN THE UNITED STATES AND 5 EUROPEAN COUNTRIES (FRANCE, GERMANY, ITALY, SPAIN, UK)
IMPACT OF TREATMENT SWITCH ON CLINICAL OUTCOMES IN CROHN’S DISEASE PATIENTS IN THE UNITED STATES AND 5 EUROPEAN COUNTRIES (FRANCE, GERMANY, ITALY, SPAIN, UK)

Timothy Hoops  et al.

IMPACT OF SUBOPTIMAL RESPONSE ON CLINICAL AND HUMANISTIC BURDEN IN CROHN’S DISEASE
IMPACT OF SUBOPTIMAL RESPONSE ON CLINICAL AND HUMANISTIC BURDEN IN CROHN’S DISEASE

Timothy Hoops  et al.

IMPACT OF DISEASE FLARES ON RESOURCE USE, HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN EUROPE: AN ANALYSIS OF NATIONAL HEALTH AND WELLNESS SURVEY DATA
IMPACT OF DISEASE FLARES ON RESOURCE USE, HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN EUROPE: AN ANALYSIS OF NATIONAL HEALTH AND WELLNESS SURVEY DATA

Timothy Hoops  et al.

IMPACT OF DISEASE FLARES ON RESOURCE USE, HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY IN PATIENTS WITH CROHN’S DISEASE IN EUROPE: AN ANALYSIS OF NATIONAL HEALTH AND WELLNESS SURVEY DATA
IMPACT OF DISEASE FLARES ON RESOURCE USE, HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY IN PATIENTS WITH CROHN’S DISEASE IN EUROPE: AN ANALYSIS OF NATIONAL HEALTH AND WELLNESS SURVEY DATA

Timothy Hoops  et al.

SERUM PROTEIN PROFILES DIFFER WITH USTEKINUMAB AND ADALIMUMAB TREATMENT IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
SERUM PROTEIN PROFILES DIFFER WITH USTEKINUMAB AND ADALIMUMAB TREATMENT IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Timothy Hoops  et al.

Item 1 - 7 / 7
1